Palmitoylethanolamide (pea) + Rivaroxaban
Rivaroxaban brand name: Xarelto.
We found no known interaction between Palmitoylethanolamide (pea) and Rivaroxaban in our sources. Absence of a documented interaction is not the same as proven safety, and does not guarantee one does not exist. Do not start, stop, or change a medication or supplement based on this page; confirm with your pharmacist or doctor first.
Palmitoylethanolamide (pea) and Rivaroxaban
We checked these two against our interaction database. Here is what we found.
No Known Interaction Found
We did not find a documented interaction between Rivaroxaban and Palmitoylethanolamide (pea) in our sources. This does not guarantee that the combination is completely free of risk — there is often limited research on supplements and herbal products, especially around drug interactions.
Worth understanding: our licensed dataset holds no drug-interaction record for Palmitoylethanolamide (pea) at all — not against Rivaroxaban, and not against any other medication we track. This verdict therefore rests on the absence of any recorded data, not on research that looked at this combination and found nothing. We cannot rule an interaction out.
If you decide to take both, the practical routine is simple: add one new thing at a time and note the date you started it. If the combination is going to disagree with you, it usually shows in the first days to a couple of weeks — and a start date turns “I’ve been feeling off” into something a pharmacist can actually work with. Do not stop a prescribed medicine on your own.
Always talk with your pharmacist or doctor before making changes to your medications or supplements, particularly if you take several medications or have an ongoing health condition.
Palmitoylethanolamide (pea) safety at a glance
Safety guidance is general; always confirm with your pharmacist or doctor for your situation.
What Rivaroxaban Is Prescribed For, and What Palmitoylethanolamide (pea) Has Been Studied For
These two come up together because they touch the same health topic — not because they do the same job. Rivaroxaban is a prescription medicine with approved uses on its FDA label. Palmitoylethanolamide (pea) is a supplement: what follows is what researchers have looked at it for, and how strong that evidence is.
Rivaroxaban is prescribed for: Rivaroxaban tablets are used to reduce the risk of stroke in adults with nonvalvular atrial fibrillation (an irregular heart rhythm), treat deep vein thrombosis (DVT, a blood clot in a vein) and pulmonary embolism (PE, a blood clot in the lungs), and lower the chances of these clots coming back. They also help prevent clots after hip or knee replacement surgery, protect hospitalized patients at risk for clots, and — in combination with aspirin — reduce the risk of major cardiovascular events in adults with coronary artery disease (CAD) or peripheral artery disease (PAD). Rivaroxaban tablets are also approved for treating VTE (venous thromboembolism, blood clots in veins) and preventing recurrence in pediatric patients from birth to under 18 years, and for preventing clots in children aged 2 and older with congenital heart disease after the Fontan procedure. Rivaroxaban for oral suspension (available as Rivaroxaban Granule and Xarelto oral suspension) is specifically indicated for these two pediatric uses.
Palmitoylethanolamide (pea) has been studied for:
-
Stroke studied, not established Palmitoylethanolamide (pea) has been studied for this. Natural Medicines rates the evidence: Insufficient Reliable Evidence To Rate Read what the research shows
Palmitoylethanolamide (pea) for stroke
Oral PEA has only been evaluated in combination with other ingredients; its effect when used alone is unclear.
Effectiveness ratings and the research summaries above are the verbatim record from the Natural Medicines database, which grades evidence from “Effective” down to “Insufficient Reliable Evidence To Rate”. A rating below the top of that scale means researchers have looked at it — not that it works, and never that it can stand in for a prescribed medicine. Do not stop or replace Rivaroxaban on your own; if you are taking Palmitoylethanolamide (pea) for the same health topic, tell your prescriber, especially if the medicine is being adjusted to a target.
Questions About Palmitoylethanolamide (pea) or Rivaroxaban
These are real questions from readers, answered by the pharmacists at HelloPharmacist — written by a person, not generated from a database. Each one covers Palmitoylethanolamide (pea) or Rivaroxaban, not necessarily both, but if one is close to what you were about to ask it will usually go further than a database entry can:
- Can You Use Cyperus Rotundus (Nut Grass) Oil With Xarelto? ›
- Can You Take Cod Liver Oil With Rivaroxaban (Xarelto)? ›
- Can You Take NAC With Xarelto (Rivaroxaban)? ›
Not quite your question? Ask our pharmacists directly — it is free, there is no account required, and answers usually come back within 24 hours.
See Every Supplement That Interacts With Rivaroxaban
This page covers Palmitoylethanolamide (pea) only. If you take other supplements — a multivitamin, a sleep aid, something for joints — the Rivaroxaban page lists 285 supplements it has a documented interaction with, worst first, each one explained.
The most serious there right now: Activated Charcoal (major), Danshen (major), Grapefruit (major), Piracetam (major) and St. John's Wort (major).
By severity: 5 major · 240 moderate · 40 minor.
From our pharmacist’s overview on the Rivaroxaban page
“Grapefruit is the interaction I would flag first for anyone taking rivaroxaban (Xarelto). It slows how the body clears this blood thinner, and higher levels mean more bleeding risk.”
Reviewed by 2 · Jul 18, 2026
Taking Palmitoylethanolamide (pea) as Part of a Dietary Supplement Product? Check It for Interactions
We hold 97 real supplement products containing Palmitoylethanolamide (pea), each one broken down to its full ingredient list — and combination products often carry several ingredients besides Palmitoylethanolamide (pea). Even though Palmitoylethanolamide (pea) itself has no known interaction with Rivaroxaban, another ingredient on your label might. Find your product and we’ll check every ingredient on its label:
Where Palmitoylethanolamide (pea) and Rivaroxaban Sit Against Everything Else
Out of every supplement and medication people look up on HelloPharmacist, here is where these two land this week — and which way each has been moving.
#483 of 1,452 supplements looked up here in the last 7 days
#10 of 2,830 medications looked up here in the last 7 days
Position among everything looked up on this site, not a measure of how commonly either one is used or how important it is. A supplement can climb this list because of a news story. It counts every request to the page, automated ones included, and nothing here identifies anyone.
Where does our data come from?
- Source: the Natural Medicines (TRC Healthcare) clinical database — the evidence-graded professional reference for herb & supplement interactions.
- Citation library: 103,510 references behind our interaction content, 65,311 of them resolved to verified PubMed/DOI sources. See every Palmitoylethanolamide (pea) reference on this page ↓
- Freshness: we automatically re-check this combination every week — this pair was last verified September 13, 2026. The Palmitoylethanolamide (pea) and Rivaroxaban records this page draws on were last updated July 10, 2026.
- What “no known interaction” means: no documented interaction in the sources above — not a guarantee of safety. Supplements are studied far less than prescription drugs, so we say exactly what the evidence supports, and nothing more.
About Palmitoylethanolamide (pea)
What is Palmitoylethanolamide (pea)?
- Chronic pain
- Nerve (neuropathic) pain
- Inflammation
- Low back and sciatica pain
- General immune and recovery support
Palmitoylethanolamide (PEA) is a fat-like molecule made naturally in the body and studied mainly for pain and inflammation. Some research suggests it may help certain types of chronic and nerve pain, but the overall evidence is still limited and more high-quality studies are needed. It appears generally well tolerated, but talk with your pharmacist or doctor before starting it.
Not a plant; a fatty acid compound made in the body and found in some foods · Capsules, tablets, sublingual tablets, powders, and 'micronized' or 'ultramicronized' formulations
An interaction check asks whether these two react with each other — it does not ask whether Palmitoylethanolamide (pea) is a good idea for someone in your situation. Here is what our Palmitoylethanolamide (pea) record says about it on its own.
Palmitoylethanolamide (pea): dosing
There is no official, standardized dose of PEA. Studies have used a range of amounts and different formulations, including micronized and ultramicronized versions, which can affect how the body absorbs it.Because of this, the best approach is to follow the directions on the product label and start with the lowest suggested amount.
From our Palmitoylethanolamide (pea) monograph — the full record covers uses, side effects and every documented interaction.
About Rivaroxaban
What Is Rivaroxaban Used For?
Brand name: Xarelto
Rivaroxaban tablets are used to reduce the risk of stroke in adults with nonvalvular atrial fibrillation (an irregular heart rhythm), treat deep vein thrombosis (DVT, a blood clot in a vein) and pulmonary embolism (PE, a blood clot in the lungs), and lower the chances of these clots coming back. They also help prevent clots after hip or knee replacement surgery, protect hospitalized patients at risk for clots, and — in combination with aspirin — reduce the risk of major cardiovascular events in adults with coronary artery disease (CAD) or peripheral artery disease (PAD).
Rivaroxaban tablets are also approved for treating VTE (venous thromboembolism, blood clots in veins) and preventing recurrence in pediatric patients from birth to under 18 years, and for preventing clots in children aged 2 and older with congenital heart disease after the Fontan procedure. Rivaroxaban for oral suspension (available as Rivaroxaban Granule and Xarelto oral suspension) is specifically indicated for these two pediatric uses.
Other Drugs & Palmitoylethanolamide (pea)
Browse every other medication we’ve checked against Palmitoylethanolamide (pea) — both the ones with a known interaction and the ones without. Select any drug for the full detail.
No drugs match “”.
No interaction 2,829 drugs checked — show the list
We also checked Palmitoylethanolamide (pea) against these medications and found no known interaction in our sources. Open any page to confirm.
- Apixaban ›
- Levothyroxine ›
- Amlodipine ›
- Methylphenidate ›
- Warfarin ›
- Sertraline ›
- Testosterone ›
- Losartan Potassium ›
- Metoprolol ›
- Aspirin ›
- Ivermectin ›
- Rosuvastatin ›
- Escitalopram ›
- Tadalafil ›
- Acetaminophen ›
- Clopidogrel ›
- Valacyclovir ›
- Atorvastatin ›
- Docusate ›
- Hydroxyurea ›
- Abemaciclib ›
- Methamphetamine ›
- Sumatriptan ›
- Ibuprofen ›
- Semaglutide ›
- Tirzepatide ›
- Warfarin Sodium ›
- Prednisone ›
- Propranolol ›
- Lisdexamfetamine ›
- Acyclovir ›
- Bupropion ›
- Metformin ›
- Amoxicillin ›
- Lisinopril ›
- Bendamustine ›
- Amitriptyline ›
- Doxycycline ›
- Lamotrigine ›
- Fluoxetine ›
- Methotrexate ›
- Acetaminophen, Codeine ›
- Gabapentin ›
- Amphetamine ›
- Pregabalin ›
- Isotretinoin ›
- Dextroamphetamine ›
- Azithromycin ›
- Clonazepam ›
- Quetiapine ›
- Omeprazole ›
- Amlodipine Besylate ›
- Methylene Blue ›
- Duloxetine ›
- Letrozole ›
- Buspirone ›
- Citalopram ›
- Ciprofloxacin ›
- Naproxen ›
- Bisoprolol ›
Showing the 60 most looked-up of 2,829 medications checked with no known interaction — see the full Palmitoylethanolamide (pea) list.
Palmitoylethanolamide (pea) References
The 4 references that drive our Palmitoylethanolamide (pea) monograph and interaction data, from the evidence-graded Natural Medicines (TRC Healthcare) database. Citations with a link open the study on PubMed or the publisher’s site.
- Indraccolo U, Barbieri F. Effect of palmitoylethanolamide-polydatin combination on chronic pelvic pain associated with endometriosis: preliminary observations. Eur J Obstet Gynecol Reprod Biol. 2010 May;150(1):76-9. PubMed
- Murina F, Graziottin A, Felice R, Radici G, Tognocchi C. Vestibulodynia: synergy between palmitoylethanolamide + transpolydatin and transcutaneous electrical nerve stimulation. J Low Genit Tract Dis. 2013 Apr;17(2):111-6.
- Papetti L, Sforza G, Tullo G, et al. Tolerability of palmitoylethanolamide in a pediatric population suffering from migraine: A pilot study. Pain Res Manag 2020;2020:3938640. PubMed
- Visse K, Blome C, Phan NQ, Augustin M, Ständer S. Efficacy of body lotion containing N-palmitoylethanolamine in subjects with chronic pruritus due to dry skin: A dermatocosmetic study. Acta Derm Venereol. 2017;97(5):639-641. PubMed
Medication overviews come from MedlinePlus (NIH); supplement label data from the NIH Dietary Supplement Label Database. Content is written and reviewed by licensed HelloPharmacist pharmacists — see our data sources and editorial standards.
Taking Palmitoylethanolamide (pea) and Rivaroxaban Together: Common Questions
Is it safe to take Palmitoylethanolamide (pea) with Rivaroxaban?
Are Palmitoylethanolamide (pea) and Rivaroxaban used for the same thing?
Does Rivaroxaban interact with any supplements?
Written and reviewed by the HelloPharmacist editorial staff. Our editorial policy
Keep Exploring
Still Have a Question About Rivaroxaban and Palmitoylethanolamide (pea)?
Our pharmacists answer your medication & supplement questions — free.
This information is for education only and is not a substitute for professional medical advice. Always check with your pharmacist or doctor before starting, stopping, or combining supplements and medications.